US Stock MarketDetailed Quotes

MBRX Moleculin Biotech

Watchlist
  • 2.8300
  • +0.1600+5.99%
Close Nov 21 16:00 ET
  • 2.8300
  • 0.00000.00%
Post 17:20 ET
8.50MMarket Cap-236P/E (TTM)

Moleculin Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Moleculin Biotech Q3 2024 Earnings Date

Currency：USDNov 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-2.44
-2.85
-0.41
Miss Est.
+14.39%
-1.06%
-16.81%
Analyst Rating
Buy

Nov 12, 2024

Moleculin Biotech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 8, 20242024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
May 10, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 8, 20242024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
May 10, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Moleculin Biotech Earnings Reports

  • Moleculin Biotech | 8-K: Moleculin Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 12 09:27 ET

  • Moleculin Biotech | 10-Q: Q3 2024 Earnings Report

    Nov 8 17:14 ET

  • Moleculin Biotech | 8-K: Moleculin Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 14 08:09 ET

  • Moleculin Biotech | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:03 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 12, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data